Living with psoriasis is often seen as a skin condition, but it involves much more than just the surface. New research highlights that psoriasis is a systemic inflammatory disease. This means the underlying inflammation can affect other parts of the body, specifically leading to a higher risk of developing type 2 diabetes in patients with moderate to severe or long-standing cases.
Scientists found that both conditions share common biological pathways. These include things like chronic systemic inflammation, problems with blood vessel function, and shared genetic risks. Because these two conditions are linked by the same underlying issues, doctors may need to look at the whole person rather than just treating one symptom at a time.
While some medications used for diabetes or psoriasis might affect both conditions, the evidence for these specific treatments is currently limited and varied. For now, recognizing the link between skin inflammation and metabolic health helps doctors provide more personalized care for patients dealing with both challenges.
Common questions
Why do people with psoriasis have a higher risk of diabetes?
Psoriasis is considered a systemic inflammatory disease, meaning the inflammation affects the whole body. Research shows that both psoriasis and type 2 diabetes share common pathways like chronic inflammation, oxidative stress, and shared genetic risks. Because of these overlapping issues, people with moderate to severe or long-standing psoriasis are more likely to develop type 2 diabetes than the general population.
Can medications for one condition help the other?
Some antidiabetic agents and biologic therapies may influence both metabolic and skin outcomes. However, it is important to note that current evidence regarding how these specific treatments affect both conditions is still limited and varied. You should talk to your doctor about which treatment plan is best for your specific needs.
Is there a direct cause between psoriasis and diabetes?
While research shows a potential bidirectional relationship between psoriatic inflammation and type 2 diabetes, the data does not establish a specific cause. The link is primarily driven by shared pathways like endothelial dysfunction and dysregulated adipokines. Because of this complexity, patients may benefit from a multidisciplinary care approach.
